The synthetic cornea from Israel’s CorNeat is beginning human trials, as reported here in July. This has become vital due to shortage of human corneas during Covid-19. CorNeat will soon begin trials of its EverPatch for Glaucoma surgery and is developing the eShunt to reduce eye pressure.
https://nocamels.com/2020/09/medtech-corneat-patented-implants-blind-diseases/